EXEL Insider Trading (Exelixis)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.50%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $29,959,887.24

Exelixis Insider Trading History Chart

Exelixis Share Price & Price History

^$22.66

▲ +0.45 (2.03%)

As of 02/24/2021 01:00 AM ET

Days: 30 | 90 | 365

Are you looking for the next great pet stock play?

From Emerging Markets Consulting | Ad

Don't miss this opportunity as FRPT is already trading over 100 dollars per share!

Read more here about the next great pet stock!

Exelixis Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/22/2021	Vincent T. Marchesi	Director	Sell	24,097	$22.29	$537,122.13	424,415
2/17/2021	Gisela Schwab	CMO	Sell	50,000	$22.50	$1,125,000.00
2/16/2021	Carl B Feldbaum	Director	Sell	20,000	$21.96	$439,200.00	28,521
2/12/2021	Patrick J. Haley	EVP	Sell	45,000	$21.57	$970,650.00
2/1/2021	Peter Lamb	EVP	Sell	65,000	$22.08	$1,435,200.00
1/12/2021	Christopher J. Senner	CFO	Sell	30,000	$25.00	$750,000.00
1/4/2021	Peter Lamb	EVP	Sell	65,000	$20.32	$1,320,800.00
12/18/2020	Peter Lamb	EVP	Sell	65,000	$20.01	$1,300,650.00
11/24/2020	Vincent T. Marchesi	Director	Sell	40,004	$18.50	$740,074.00
11/10/2020	Jack L. Wyszomierski	Director	Sell	34,000	$20.61	$700,740.00
10/21/2020	Jeffrey Hessekiel	EVP	Sell	39,742	$21.95	$872,336.90
10/8/2020	Christopher J. Senner	CFO	Sell	10,000	$25.00	$250,000.00
9/21/2020	Patrick J. Haley	EVP	Sell	4,680	$26.09	$122,101.20
9/15/2020	Christopher J. Senner	CFO	Sell	20,000	$25.00	$500,000.00
7/20/2020	Patrick J. Haley	EVP	Sell	3,151	$25.36	$79,909.36
6/8/2020	Peter Lamb	EVP	Sell	26,000	$22.56	$586,560.00
6/4/2020	Gisela Schwab	CMO	Sell	100,000	$22.96	$2,296,000.00
5/21/2020	Vincent T. Marchesi	Director	Sell	40,000	$24.64	$985,600.00	12,718
5/20/2020	Patrick J. Haley	EVP	Sell	3,151	$24.99	$78,743.49
5/18/2020	Lance Willsey	Director	Sell	30,000	$26.26	$787,800.00	398,273
5/14/2020	Lance Willsey	Director	Sell	15,000	$25.26	$378,900.00	383,273
5/11/2020	Jeffrey Hessekiel	EVP	Sell	38,006	$27.09	$1,029,582.54
5/11/2020	Vincent T. Marchesi	Director	Sell	30,000	$26.30	$789,000.00
5/8/2020	Patrick J. Haley	EVP	Sell	21,375	$25.87	$552,971.25
5/8/2020	Stelios Papadopoulos	Director	Sell	45,000	$25.84	$1,162,800.00
5/7/2020	Christopher J. Senner	CFO	Sell	21,417	$25.80	$552,558.60
4/24/2020	George A Scangos	Director	Sell	15,000	$26.24	$393,600.00	808,731
4/23/2020	Gisela Schwab	CMO	Sell	100,000	$26.00	$2,600,000.00
4/23/2020	Patrick J. Haley	EVP	Sell	5,000	$26.00	$130,000.00
4/22/2020	George A Scangos	Director	Sell	4,200	$25.05	$105,210.00	894,531
4/20/2020	George A Scangos	Director	Sell	50,000	$23.89	$1,194,500.00	894,531
4/20/2020	Patrick J. Haley	EVP	Sell	5,000	$24.00	$120,000.00
4/15/2020	George A Scangos	Director	Sell	25,000	$18.31	$457,750.00	913,031
4/7/2020	George A Scangos	Director	Sell	16,435	$18.25	$299,938.75	945,096
4/6/2020	Peter Lamb	EVP	Sell	50,000	$17.26	$863,000.00
4/3/2020	Jack L. Wyszomierski	Director	Sell	13,848	$16.57	$229,461.36
3/31/2020	George A Scangos	Director	Sell	1,500	$18.06	$27,090.00	961,531
3/20/2020	Patrick J. Haley	EVP	Sell	4,318	$15.37	$66,367.66
3/4/2020	Gisela Schwab	CMO	Sell	100,000	$19.40	$1,940,000.00
3/3/2020	Carl B Feldbaum	Director	Sell	38,000	$18.84	$715,920.00	40,521
2/26/2020	Michael Morrissey	CEO	Sell	25,000	$18.91	$472,750.00
2/19/2020	Gisela Schwab	CMO	Sell	40,000	$21.50	$860,000.00
2/19/2020	Michael Morrissey	CEO	Sell	25,000	$21.75	$543,750.00
2/19/2020	Patrick J. Haley	EVP	Sell	5,000	$22.00	$110,000.00
2/18/2020	George A Scangos	Director	Sell	50,000	$20.73	$1,036,500.00	963,031
2/14/2020	Alan M Garber	Director	Sell	12,500	$21.02	$262,750.00	48,829
2/13/2020	Michael Morrissey	CEO	Sell	25,000	$20.11	$502,750.00
2/11/2020	George A Scangos	Director	Sell	4,000	$20.14	$80,560.00	1,034,031
2/7/2020	Gisela Schwab	CMO	Sell	50,000	$18.37	$918,500.00
1/29/2020	Michael Morrissey	CEO	Sell	25,000	$17.87	$446,750.00
1/23/2020	Michael Morrissey	CEO	Sell	25,000	$19.41	$485,250.00	1,038,031
1/16/2020	Michael Morrissey	CEO	Sell	25,000	$20.33	$508,250.00
1/15/2020	Vincent T. Marchesi	Director	Sell	61,683	$20.01	$1,234,276.83
1/8/2020	Michael Morrissey	CEO	Sell	25,000	$18.85	$471,250.00
1/7/2020	Alan M Garber	Director	Sell	86,956	$18.01	$1,566,077.56	91,329
1/7/2020	Gisela Schwab	CMO	Sell	50,000	$17.96	$898,000.00
1/2/2020	Michael Morrissey	CEO	Sell	25,000	$17.49	$437,250.00
12/3/2019	Gisela Schwab	CMO	Sell	50,000	$17.36	$868,000.00
11/4/2019	Gisela Schwab	CMO	Sell	50,000	$15.99	$799,500.00
10/10/2019	Patrick J. Haley	VP	Sell	303	$16.27	$4,929.81
10/2/2019	Michael Morrissey	CEO	Sell	26,364	$17.66	$465,588.24
10/1/2019	Gisela Schwab	CMO	Sell	30,000	$17.87	$536,100.00
9/18/2019	Michael Morrissey	CEO	Sell	37,227	$19.20	$714,758.40
9/10/2019	Patrick J. Haley	VP	Sell	1,000	$18.84	$18,840.00
8/16/2019	George Poste	Director	Sell	25,000	$20.50	$512,500.00
8/16/2019	Jeffrey Hessekiel	EVP	Sell	75,000	$21.10	$1,582,500.00
8/14/2019	Michael Morrissey	CEO	Sell	35,040	$20.11	$704,654.40
8/12/2019	Patrick J. Haley	VP	Sell	1,000	$20.39	$20,390.00
8/9/2019	George Poste	Director	Sell	20,000	$20.60	$412,000.00
8/6/2019	Patrick J. Haley	Insider	Sell	25,000	$20.02	$500,500.00
8/2/2019	Michael Morrissey	Insider	Sell	35,040	$20.25	$709,560.00
8/1/2019	George A Scangos	Director	Sell	40,000	$20.59	$823,600.00	1,134,081
7/17/2019	Michael Morrissey	CEO	Sell	34,721	$21.37	$741,987.77
7/10/2019	Patrick J. Haley	Insider	Sell	1,000	$20.96	$20,960.00
7/3/2019	Michael Morrissey	CEO	Sell	34,721	$21.03	$730,182.63
7/1/2019	George A Scangos	Director	Sell	40,000	$21.58	$863,200.00	1,168,031
6/17/2019	Peter Lamb	EVP	Sell	217,404	$20.59	$4,476,348.36
6/13/2019	Peter Lamb	EVP	Sell	27,596	$20.03	$552,747.88
6/10/2019	Patrick J. Haley	Insider	Sell	1,000	$20.23	$20,230.00
6/4/2019	George A Scangos	Director	Sell	40,000	$19.76	$790,400.00	1,223,031
5/10/2019	Patrick J. Haley	Insider	Sell	1,000	$19.58	$19,580.00
5/8/2019	Lance Willsey	Director	Sell	50,000	$20.36	$1,018,000.00	368,273
5/8/2019	Michael Morrissey	Insider	Sell	42,000	$20.15	$846,300.00
5/3/2019	Christopher J. Senner	CFO	Sell	36,261	$20.70	$750,602.70
5/2/2019	George A Scangos	Director	Sell	40,000	$19.84	$793,600.00	1,248,031
4/24/2019	Michael Morrissey	Insider	Sell	40,000	$20.75	$830,000.00
4/10/2019	Michael Morrissey	Insider	Sell	40,000	$24.06	$962,400.00
4/10/2019	Patrick J. Haley	VP	Sell	1,000	$24.04	$24,040.00
4/3/2019	George A Scangos	Director	Sell	5,000	$25.03	$125,150.00	1,278,031
4/3/2019	Gisela Schwab	Insider	Sell	63,109	$25.00	$1,577,725.00
4/1/2019	Alan M Garber	Director	Sell	30,000	$23.99	$719,700.00	76,329
4/1/2019	Jeffrey Hessekiel	EVP	Sell	20,000	$24.03	$480,600.00
3/29/2019	George Poste	Director	Sell	3,860	$23.89	$92,215.40
3/27/2019	Michael Morrissey	CEO	Sell	40,000	$23.39	$935,600.00
3/26/2019	Patrick J. Haley	Insider	Sell	2,700	$23.47	$63,369.00
3/25/2019	Gisela Schwab	CMO	Sell	100,000	$23.14	$2,314,000.00
3/14/2019	George A Scangos	Director	Sell	5,000	$25.00	$125,000.00	1,318,031
3/14/2019	Patrick J. Haley	Insider	Sell	2,000	$25.00	$50,000.00
3/13/2019	Michael Morrissey	CEO	Sell	40,000	$24.64	$985,600.00
3/11/2019	Patrick J. Haley	VP	Sell	959	$23.13	$22,181.67
3/1/2019	George A Scangos	Director	Sell	40,000	$22.66	$906,400.00	1,323,031
2/27/2019	Michael Morrissey	CEO	Sell	40,000	$22.69	$907,600.00
2/25/2019	Charles Cohen	Director	Sell	5,271	$22.18	$116,910.78	11,250
2/25/2019	Patrick J. Haley	Insider	Sell	4,272	$22.27	$95,137.44
2/22/2019	Vincent T. Marchesi	Director	Sell	41,250	$21.50	$886,875.00
2/19/2019	Charles Cohen	Director	Sell	248,180	$22.14	$5,494,705.20	148,180
2/14/2019	Carl B Feldbaum	Director	Sell	50,500	$22.03	$1,112,515.00	30,221
2/14/2019	Gisela Schwab	CMO	Sell	100,000	$21.66	$2,166,000.00	148,180
2/14/2019	Michael Morrissey	CEO	Sell	40,000	$22.39	$895,600.00
2/11/2019	Patrick J. Haley	Insider	Sell	1,000	$21.30	$21,300.00
2/1/2019	George A Scangos	Director	Sell	40,000	$23.53	$941,200.00	1,363,031
1/30/2019	Michael Morrissey	Insider	Sell	40,000	$23.12	$924,800.00
1/16/2019	Michael Morrissey	Insider	Sell	40,000	$23.29	$931,600.00
1/9/2019	Patrick J. Haley	Insider	Sell	9,120	$22.18	$202,281.60
1/9/2019	Patrick J. Haley	VP	Sell	1,560	$23.50	$36,660.00
1/8/2019	Alan M Garber	Director	Sell	11,250	$23.00	$258,750.00	72,579
1/7/2019	Patrick J. Haley	VP	Sell	5,560	$21.51	$119,595.60
1/4/2019	Michael Morrissey	Insider	Sell	40,000	$20.11	$804,400.00
1/3/2019	Patrick J. Haley	VP	Sell	8,000	$19.95	$159,600.00
1/2/2019	George A Scangos	Director	Sell	39,904	$19.64	$783,714.56	1,452,331
1/2/2019	Michael Morrissey	CEO	Sell	6,046	$20.00	$120,920.00
12/3/2018	George A Scangos	Director	Sell	40,000	$21.16	$846,400.00	1,505,481
12/3/2018	Gisela Schwab	Insider	Sell	13,499	$21.02	$283,748.98
11/30/2018	Christopher J. Senner	CFO	Sell	8,791	$19.70	$173,182.70
11/30/2018	Jeffrey Hessekiel	EVP	Sell	14,818	$19.25	$285,246.50
11/29/2018	George A Scangos	Director	Sell	6,500	$20.00	$130,000.00	1,505,481
11/28/2018	Jeffrey Hessekiel	EVP	Sell	11,759	$19.12	$224,832.08
11/15/2018	Michael Morrissey	Insider	Sell	25,000	$17.22	$430,500.00
11/7/2018	Patrick J. Haley	Insider	Sell	20,000	$17.32	$346,400.00
11/2/2018	Michael Morrissey	Insider	Sell	37,499	$17.57	$658,857.43
11/1/2018	George A Scangos	Director	Sell	25,000	$14.66	$366,500.00	1,521,981
11/1/2018	Gisela Schwab	CMO	Sell	12,000	$14.16	$169,920.00
10/1/2018	George A Scangos	Director	Sell	25,000	$17.86	$446,500.00	1,536,981
10/1/2018	Gisela Schwab	Insider	Sell	12,000	$17.77	$213,240.00
10/1/2018	Michael Morrissey	CEO	Sell	12,501	$17.82	$222,767.82
9/24/2018	George A Scangos	Director	Sell	25,000	$16.85	$421,250.00	1,561,981
9/4/2018	Gisela Schwab	Insider	Sell	22,500	$18.53	$416,925.00
8/20/2018	Michael Morrissey	Insider	Sell	90,000	$17.82	$1,603,800.00
8/15/2018	Vincent T. Marchesi	Director	Sell	40,000	$19.50	$780,000.00
8/9/2018	Michael Morrissey	Insider	Sell	234,267	$21.04	$4,928,977.68
8/7/2018	Michael Morrissey	CEO	Sell	100,000	$21.10	$2,110,000.00
8/6/2018	Patrick J. Haley	Insider	Sell	2,361	$20.92	$49,392.12
8/1/2018	Gisela Schwab	Insider	Sell	22,500	$20.56	$462,600.00
7/16/2018	Michael Morrissey	Insider	Sell	90,000	$21.13	$1,901,700.00
7/2/2018	Gisela Schwab	CMO	Sell	22,500	$21.20	$477,000.00
6/25/2018	Michael Morrissey	Insider	Sell	90,000	$19.62	$1,765,800.00
6/1/2018	Gisela Schwab	Insider	Sell	22,500	$20.80	$468,000.00
5/31/2018	Jeffrey Hessekiel	EVP	Sell	65,000	$20.71	$1,346,150.00
5/30/2018	Carl B Feldbaum	Director	Sell	34,262	$20.60	$705,797.20	45,983
5/24/2018	Michael Morrissey	Insider	Sell	90,000	$20.55	$1,849,500.00
5/22/2018	Lance Willsey	Director	Sell	50,000	$21.40	$1,070,000.00	418,273
5/18/2018	Patrick J. Haley	VP	Sell	3,663	$21.61	$79,157.43
5/11/2018	Vincent T. Marchesi	Director	Sell	15,000	$19.03	$285,450.00
5/9/2018	Charles Cohen	Director	Sell	15,000	$21.42	$321,300.00	263,180
5/7/2018	Patrick J. Haley	Insider	Sell	27,549	$22.17	$610,761.33
5/7/2018	Stelios Papadopoulos	Director	Sell	15,000	$22.15	$332,250.00
5/4/2018	Jeffrey Hessekiel	EVP	Sell	20,000	$22.36	$447,200.00
5/4/2018	Patrick J. Haley	VP	Sell	12,549	$22.38	$280,846.62
5/3/2018	Gisela Schwab	CMO	Sell	22,500	$23.09	$519,525.00
4/16/2018	Alan M Garber	Director	Sell	15,000	$20.25	$303,750.00	76,329
4/11/2018	Michael Morrissey	Insider	Sell	90,000	$20.78	$1,870,200.00
3/6/2018	Vincent T. Marchesi	Director	Sell	15,000	$24.73	$370,950.00
3/2/2018	Lance Willsey	Director	Sell	30,000	$23.91	$717,300.00	483,273
2/28/2018	George Poste	Director	Sell	15,000	$26.26	$393,900.00
2/28/2018	Patrick J. Haley	VP	Sell	45,029	$27.13	$1,221,636.77

SEC Filings (Institutional Ownership Changes) for Exelixis (NASDAQ:EXEL)

81.37% of Exelixis stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Exelixis Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/24/2021	Virtu Financial LLC	17,300	$0.35M	0.0%	N/A	0.006%
2/23/2021	Principal Financial Group Inc.	925,400	$18.57M	0.0%	+0.3%	0.297%
2/19/2021	JPMorgan Chase & Co.	11,662,211	$234.06M	0.0%	+19.4%	3.738%
2/19/2021	AtonRa Partners	103,080	$2.07M	1.0%	N/A	0.033%
2/19/2021	Laffer Tengler Investments	2,585	$52K	0.0%	N/A	0.001%
2/18/2021	Truist Financial Corp	45,097	$0.91M	0.0%	+120.2%	0.014%
2/17/2021	Twinbeech Capital LP	44,876	$0.90M	0.1%	N/A	0.014%
2/17/2021	Canada Pension Plan Investment Board	79,065	$1.59M	0.0%	+47.3%	0.025%
2/16/2021	Squarepoint Ops LLC	101,007	$2.03M	0.0%	+71.1%	0.033%
2/16/2021	Morgan Stanley	559,254	$11.23M	0.0%	+52.3%	0.180%
2/16/2021	Mariner LLC	20,474	$0.41M	0.0%	+41.6%	0.007%
2/16/2021	Rice Hall James & Associates LLC	105,099	$2.11M	0.1%	-13.0%	0.034%
2/16/2021	Nuveen Asset Management LLC	1,330,350	$26.70M	0.0%	+5.4%	0.429%
2/16/2021	Colony Group LLC	141,662	$2.84M	0.1%	+2.9%	0.046%
2/16/2021	Guggenheim Capital LLC	283,640	$5.69M	0.0%	+13.5%	0.091%
2/16/2021	Price T Rowe Associates Inc. MD	17,588,494	$353M	0.0%	+28.9%	5.669%
2/16/2021	Amundi Pioneer Asset Management Inc.	30,700	$0.62M	0.0%	-3.6%	0.010%
2/16/2021	Virginia Retirement Systems ET AL	84,800	$1.70M	0.0%	+20.1%	0.027%
2/16/2021	Engineers Gate Manager LP	51,624	$1.04M	0.0%	+298.3%	0.017%
2/16/2021	Janus Henderson Group PLC	874,031	$17.54M	0.0%	-80.2%	0.282%
2/16/2021	Charles Schwab Investment Management Inc.	1,535,772	$30.82M	0.0%	+1.4%	0.495%
2/13/2021	American International Group Inc.	561,129	$11.26M	0.0%	-1.2%	0.181%
2/13/2021	Oak Associates Ltd. OH	96,090	$1.93M	0.1%	N/A	0.031%
2/12/2021	Stifel Financial Corp	116,097	$2.33M	0.0%	+11.7%	0.037%
2/12/2021	Federated Hermes Inc.	100,864	$2.02M	0.0%	-7.1%	0.033%
2/12/2021	LPL Financial LLC	21,662	$0.44M	0.0%	+4.0%	0.007%
2/12/2021	Amalgamated Bank	49,614	$1M	0.0%	+1.4%	0.016%
2/12/2021	Public Employees Retirement System of Ohio	151,035	$3.03M	0.0%	+25.4%	0.049%
2/12/2021	The Manufacturers Life Insurance Company	373,434	$7.50M	0.0%	-7.8%	0.120%
2/12/2021	Nordea Investment Management AB	293,973	$5.90M	0.0%	+7.1%	0.095%
2/12/2021	Vontobel Holding Ltd.	18,250	$0.44M	0.0%	N/A	0.006%
2/12/2021	Virtus ETF Advisers LLC	29,602	$0.59M	0.2%	+13.4%	0.010%
2/12/2021	Regal Investment Advisors LLC	31,731	$0.64M	0.1%	N/A	0.010%
2/12/2021	Mercer Global Advisors Inc. ADV	57,163	$1.15M	0.0%	-10.6%	0.018%
2/12/2021	Twin Tree Management LP	28,356	$0.57M	0.0%	+642.9%	0.009%
2/11/2021	Lazard Asset Management LLC	1,464,606	$29.39M	0.0%	+24.7%	0.472%
2/11/2021	Fuller & Thaler Asset Management Inc.	196,335	$3.94M	0.0%	+8.4%	0.063%
2/11/2021	Trexquant Investment LP	18,762	$0.38M	0.0%	-75.8%	0.006%
2/11/2021	Northern Trust Corp	2,407,516	$48.32M	0.0%	-0.3%	0.776%
2/11/2021	Archer Investment Corp	2,750	$55K	0.0%	-26.7%	0.001%
2/11/2021	Burney Co.	34,585	$0.69M	0.0%	-80.7%	0.011%
2/11/2021	Teacher Retirement System of Texas	28,188	$0.57M	0.0%	+60.0%	0.009%
2/11/2021	Skandinaviska Enskilda Banken AB publ	129,400	$2.60M	0.0%	-1.0%	0.042%
2/11/2021	Oppenheimer Asset Management Inc.	42,939	$0.86M	0.0%	-6.3%	0.014%
2/10/2021	Rhumbline Advisers	838,989	$16.84M	0.0%	-1.8%	0.270%
2/10/2021	Renaissance Technologies LLC	21,682,651	$435.17M	0.5%	-4.3%	6.989%
2/10/2021	Stephens Investment Management Group LLC	1,409,846	$28.30M	0.4%	-2.4%	0.454%
2/10/2021	TD Ameritrade Investment Management LLC	3,140	$63K	0.0%	N/A	0.001%
2/10/2021	Aviva PLC	49,179	$0.99M	0.0%	-44.8%	0.016%
2/10/2021	Panagora Asset Management Inc.	133,574	$2.68M	0.0%	-44.5%	0.043%
2/10/2021	HighTower Advisors LLC	37,561	$0.75M	0.0%	+9.2%	0.012%
2/10/2021	LS Investment Advisors LLC	24,030	$0.48M	0.0%	+5.4%	0.008%
2/9/2021	Wells Fargo & Company MN	503,867	$10.11M	0.0%	-8.9%	0.162%
2/9/2021	Hancock Whitney Corp	120,251	$2.41M	0.1%	-19.4%	0.039%
2/9/2021	Advisory Services Network LLC	2,360	$47K	0.0%	+164.0%	0.001%
2/9/2021	Duality Advisers LP	72,022	$1.45M	0.1%	N/A	0.023%
2/9/2021	Fiera Capital Corp	2,559,450	$51.37M	0.1%	-0.4%	0.825%
2/9/2021	STA Wealth Management LLC	21,020	$0.42M	0.0%	+109.3%	0.007%
2/9/2021	Seven Eight Capital LP	82,300	$1.65M	0.4%	N/A	0.027%
2/9/2021	Keybank National Association OH	44,336	$0.89M	0.0%	+35.7%	0.014%
2/9/2021	Donoghue Forlines LLC	28,770	$0.58M	0.1%	N/A	0.009%
2/9/2021	Bank of New York Mellon Corp	3,110,785	$62.43M	0.0%	-3.4%	1.003%
2/9/2021	Illinois Municipal Retirement Fund	37,170	$0.75M	0.0%	+80.3%	0.012%
2/9/2021	Oregon Public Employees Retirement Fund	102,211	$2.05M	0.0%	-1.9%	0.033%
2/9/2021	NBW Capital LLC	47,322	$0.95M	0.3%	-9.6%	0.015%
2/9/2021	Lord Abbett & CO. LLC	411,200	$8.25M	0.0%	-46.9%	0.133%
2/9/2021	Blair William & Co. IL	1,557,786	$31.27M	0.1%	-35.0%	0.502%
2/9/2021	Blume Capital Management Inc.	3,712	$75K	0.0%	+16.0%	0.001%
2/9/2021	ProShare Advisors LLC	77,747	$1.56M	0.0%	+2.3%	0.025%
2/9/2021	Profund Advisors LLC	86,632	$1.74M	0.1%	+8.3%	0.028%
2/8/2021	Alliancebernstein L.P.	651,412	$13.07M	0.0%	-8.2%	0.210%
2/8/2021	Principal Financial Group Inc.	925,400	$18.57M	0.0%	+0.3%	0.298%
2/8/2021	State Board of Administration of Florida Retirement System	409,780	$8.22M	0.0%	+6.0%	0.132%
2/8/2021	New York State Common Retirement Fund	1,215,281	$24.39M	0.0%	+3.4%	0.392%
2/8/2021	FIL Ltd	530,182	$10.64M	0.0%	+205.6%	0.171%
2/8/2021	Russell Investments Group Ltd.	261,624	$5.25M	0.0%	+28.8%	0.084%
2/6/2021	Pzena Investment Management LLC	28,377	$0.57M	0.0%	+36.3%	0.009%
2/5/2021	BlackRock Inc.	31,387,574	$629.95M	0.0%	+2.5%	10.117%
2/5/2021	Aperio Group LLC	59,100	$1.19M	0.0%	-15.0%	0.019%
2/5/2021	Swiss National Bank	698,600	$14.02M	0.0%	+0.5%	0.225%
2/5/2021	SG Americas Securities LLC	175,609	$3.52M	0.0%	+37.4%	0.057%
2/5/2021	US Bancorp DE	31,253	$0.63M	0.0%	+3.7%	0.010%
2/5/2021	Capital Management Corp VA	267,556	$5.37M	1.5%	+100.7%	0.086%
2/4/2021	Texas Permanent School Fund	249,111	$5M	0.1%	-16.9%	0.080%
2/4/2021	Cambridge Investment Research Advisors Inc.	85,123	$1.71M	0.0%	+21.8%	0.027%
2/4/2021	State of Wisconsin Investment Board	322,717	$6.48M	0.0%	-0.4%	0.104%
2/4/2021	Cambiar Investors LLC	445,362	$8.94M	0.3%	+35.6%	0.144%
2/3/2021	State of New Jersey Common Pension Fund D	207,539	$4.17M	0.0%	-5.4%	0.067%
2/2/2021	Treasurer of the State of North Carolina	113,015	$2.27M	0.0%	-20.2%	0.036%
2/2/2021	California Public Employees Retirement System	754,189	$15.14M	0.0%	+7.8%	0.243%
2/2/2021	First Trust Advisors LP	3,349,143	$67.22M	0.1%	-15.6%	1.080%
2/1/2021	NN Investment Partners Holdings N.V.	90,300	$1.81M	0.0%	+573.9%	0.029%
2/1/2021	State of Michigan Retirement System	113,058	$2.27M	0.0%	+0.4%	0.036%
2/1/2021	Tandem Capital Management Corp ADV	15,420	$0.31M	0.2%	+10.1%	0.005%
2/1/2021	Victory Capital Management Inc.	207,946	$4.17M	0.0%	-12.2%	0.067%
2/1/2021	Hussman Strategic Advisors Inc.	102,500	$2.06M	0.5%	+34.0%	0.033%
2/1/2021	Assenagon Asset Management S.A.	2,208,308	$44.32M	0.2%	N/A	0.712%
1/30/2021	Bender Robert & Associates	85,545	$1.72M	0.5%	-2.3%	0.028%
1/29/2021	Creative Planning	119,159	$2.39M	0.0%	+47.5%	0.038%
1/28/2021	Fieldpoint Private Securities LLC	7,537	$0.15M	0.0%	N/A	0.002%

Data available starting January 2016

Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ capsules for the treatment of patients with progressive and metastatic medullary thyroid cancer. Its CABOMETYX and COMETRIQ are derived from cabozantinib, an inhibitor of multiple tyrosine kinases, including MET, AXL, RET, and VEGF receptors. The company also offers COTELLIC, an inhibitor of MEK as a combination regimen to treat advanced melanoma; and MINNEBRO, an oral non-steroidal selective blocker of the mineralocorticoid receptor for the treatment of hypertension in Japan. In addition, Exelixis, Inc. is developing XL092, an oral tyrosine kinase inhibitor that targets VEGF receptors, MET, AXL, MER, and other kinases implicated in growth and spread of cancer. Exelixis, Inc. has research collaborations and license agreements with Ipsen Pharma SAS; Takeda Pharmaceutical Company Ltd.; F. Hoffmann-La Roche Ltd.; Redwood Bioscience, Inc.; R.P. Scherer Technologies, LLC; Catalent Pharma Solutions, Inc.; NBE Therapeutics AG; Aurigene Discovery Technologies Limited; Iconic Therapeutics, Inc.; Invenra, Inc.; StemSynergy Therapeutics, Inc.; Genentech, Inc.; GlaxoSmithKline; Bristol-Myers Squibb Company; and Daiichi Sankyo Company, Limited. The company was formerly known as Exelixis Pharmaceuticals, Inc. and changed its name to Exelixis, Inc. in February 2000. Exelixis, Inc. was founded in 1994 and is headquartered in Alameda, California.

Today's Range

Now: $22.66

$22.20

$22.84

50 Day Range

MA: $22.74

$21.32

$25.22

52 Week Range

Now: $22.66

$13.67

$27.80

Volume

1,409,643 shs

Average Volume

2,570,767 shs

Market Capitalization

$7.07 billion

P/E Ratio

47.21

Dividend Yield

N/A

Beta

1.21

Who are the company insiders with the largest holdings of Exelixis?

Exelixis' top insider shareholders include:

George A Scangos (Director)
Michael Morrissey (CEO)
Vincent T Marchesi (Director)
Lance Willsey (Director)
Alan M Garber (Director)
Carl B Feldbaum (Director)
Charles Cohen (Director)
Christopher J Senner (CFO)
George Poste (Director)
Gisela Schwab (CMO)
Gisela Schwab (Insider)
Jack L Wyszomierski (Director)
Jeffrey Hessekiel (EVP)
Michael Morrissey (Insider)
Patrick J Haley (EVP)
Patrick J Haley (Insider)
Patrick J Haley (VP)
Peter Lamb (EVP)
Stelios Papadopoulos (Director)

Who are the major institutional investors of Exelixis?

Exelixis' top institutional investors include:

BlackRock Inc. — 10.12%
Renaissance Technologies LLC — 6.99%
Price T Rowe Associates Inc. MD — 5.67%
Meditor Group Ltd — 4.06%
JPMorgan Chase & Co. — 3.74%
First Trust Advisors LP — 1.08%

Which major investors are selling Exelixis stock?

During the previous quarter, EXEL stock was sold by these institutional investors:

Janus Henderson Group PLC
Renaissance Technologies LLC
Blair William & Co. IL
First Trust Advisors LP
Chicago Capital LLC
Lord Abbett & CO. LLC
Meditor Group Ltd
Burney Co.

Within the previous year, company insiders that have sold Exelixis company stock include:

George A Scangos (Director)
Michael Morrissey (CEO)
Vincent T Marchesi (Director)
Lance Willsey (Director)
Alan M Garber (Director)
Carl B Feldbaum (Director)
Charles Cohen (Director)
Christopher J Senner (CFO)
George Poste (Director)
Gisela Schwab (CMO)
Gisela Schwab (Insider)
Jack L Wyszomierski (Director)

Which major investors are buying Exelixis stock?

In the previous quarter, EXEL stock was acquired by institutional investors including:

Price T Rowe Associates Inc. MD
Assenagon Asset Management S.A.
JPMorgan Chase & Co.
Candriam Luxembourg S.C.A.
BlackRock Inc.
Scout Investments Inc.
FIL Ltd
Lazard Asset Management LLC